YMSLABS

Chemical entities development and pharmaceutical intermediates in India.

About YMSLABS

YMSLABS is a Chemicals & Materials company. Chemical entities development and pharmaceutical intermediates in India. The company has 55 employees. Its Indian entity Yms Laboratories Private Limited reported revenue of β‚Ή36.29 Cr. YMSLABS offers products and services including Pyridine Derivatives and Pharmaceutical Bulk Drug Intermediates. Its focus areas include Chemicals, Pharmaceutical Manufacturing, Bulk Drug Intermediates and Chemical Scaling.

Company details

YMS Laboratories Pvt. Ltd. is noted for its emphasis on the development of new chemical entities, where optimization and scaling processes from gram to multi-ton scales are undertaken. The company was established in 2011 under the Indian Companies Act, 1956, with its registered office located in Hyderabad, Telangana, India, and manufacturing facilities positioned in Raichur, Karnataka, India. Research and development efforts are supported by dedicated centers, focusing on pyridine derivatives and pharmaceutical bulk drug intermediates to meet industry demands. Operational activities are managed through B2B models, ensuring compliance and efficiency in chemical production.

  • Employees 55
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ymslabs.com
  • Legal Name Y M S Laboratories Pvt. Ltd
  • Date of Incorporation 07 Mar, 2011
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Indian entity revenue
    ₹36.29 Cr

    FY 2024 · +34% YoY

  • Indian entity net profit
    ₹2.09 Cr

    FY 2024 · 6% margin

  • Indian entity EBITDA
    ₹4.62 Cr

    FY 2024 · 13% margin

  • Employee Count
    55

Products & Services of YMSLABS

YMSLABS offers a comprehensive portfolio of products and services, including Pyridine Derivatives and Pharmaceutical Bulk Drug Intermediates.

Pyridine Derivatives
Chemical Products

Pyridine derivatives are developed and scaled for pharmaceutical uses

Pharmaceutical Bulk Drug Intermediates
Intermediate Products

Pharmaceutical bulk drug intermediates are optimized and manufactured for drug production processes

Board of directors of Yms Laboratories Private Limited (YMSLABS)

Yms Laboratories Private Limited is the primary company behind YMSLABS. The board of Yms Laboratories Private Limited currently have 2 directors; the longest-serving is Penumatsa Sivasai Dattatreyavarma, appointed in 2013. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Penumatsa Sivasai Dattatreyavarma
DIN 06593337
Director11 Nov 201313 yrsYms Laboratories Private Limited
Bangar Raju Kanumuri
DIN 06758960
Director11 Nov 201313 yrsYms Laboratories Private Limited

Financials of YMSLABS

Figures of Yms Laboratories Private Limited, the primary company behind YMSLABS, for FY 2024. Revenue was ₹36.29 Cr (+34% year on year). Net profit was ₹2.09 Cr (6% margin). EBITDA was ₹4.62 Cr (13% margin). Revenue has grown at a compounded annual rate of +76% over three years and +34% over five years.

  • ₹36.29 CrRevenue · FY 2024 · +34% YoY
  • ₹2.09 CrNet profit · 6% margin
  • ₹4.62 CrEBITDA · 13% margin
  • ₹4.61 CrPaid-up capital
  • 55Employees (provident fund records)
  • +76%Revenue CAGR, 3 years
  • +34%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Yms Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for YMSLABS

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about YMSLABS

YMSLABS has 55 employees.

The primary company behind YMSLABS, Yms Laboratories Private Limited, reported revenue of β‚Ή36.29 Cr for FY 2024, up 34% year on year.

YMS Laboratories Pvt. Ltd. is noted for its emphasis on the development of new chemical entities, where optimization and scaling processes from gram to multi-ton scales are undertaken. The company was established in 2011 under the Indian Companies Act, 1956, with its registered office located in Hyderabad, Telangana, India, and manufacturing facilities positioned in Raichur, Karnataka, India. Research and development efforts are supported by dedicated centers, focusing on pyridine derivatives and pharmaceutical bulk drug intermediates to meet industry demands. Operational activities are managed through B2B models, ensuring compliance and efficiency in chemical production.

YMSLABS offers Pyridine Derivatives and Pharmaceutical Bulk Drug Intermediates.

YMSLABS operates through Yms Laboratories Private Limited.

The legal entities of YMSLABS currently have 2 directors, including Penumatsa Sivasai Dattatreyavarma, Bangar Raju Kanumuri.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available